Multidisciplinary perspectives on newly revised 2018 FIGO staging of cancer of the cervix uteri

Jonathan S Berek¹, Koji Matsuo^{2

3}, Brendan H Grubbs⁴, David K Gaffney⁵, Susanna I Lee⁶, Aoife Kilcoyne⁶, Gi Jeong Cheon⁷, Chong Woo Yoo⁸, Lu Li^{9

10}, Yifeng Shao¹¹, Tianhui Chen¹², Miseon Kim¹³, Mikio Mikami¹⁴

Affiliations

¹ Stanford Women's Cancer Center, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
² Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA, USA.
³ Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
⁴ Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA, USA.
⁵ Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, Salt Lake City, UT, USA.
⁶ Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
⁷ Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea.
⁸ Department of Pathology, National Cancer Center, Goyang, Korea.
⁹ College of Basic Medical Sciences, Zhejiang Chinese Medical University (ZCMU), Hangzhou, China.
¹⁰ Department of Obstetrics & Gynaecology, The Chinese University of Hong Kong, Hong Kong, China.
¹¹ Department of Obstetrics and Gynecology, 1st affiliated hospital, Zhejiang Chinese Medical University, Hangzhou, China.
¹² Group of Molecular Epidemiology & Cancer Precision Prevention (GMECPP), Zhejiang Academy of Medical Sciences (ZJAMS), Hangzhou, China.
¹³ Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University School of Medicine, Seoul, Korea.
¹⁴ Department of Obstetrics and Gynecology, Tokai University School of Medicine, Kanagawa, Japan. mmikami@is.icc.u-tokai.ac.jp.

PMID: 30740962
PMCID: PMC6393641
DOI: 10.3802/jgo.2019.30.e40

Review

Multidisciplinary perspectives on newly revised 2018 FIGO staging of cancer of the cervix uteri

Jonathan S Berek et al. J Gynecol Oncol. 2019 Mar.

. 2019 Mar;30(2):e40.

doi: 10.3802/jgo.2019.30.e40. Epub 2018 Dec 28.

Authors

Affiliations

¹ Stanford Women's Cancer Center, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
² Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA, USA.
³ Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
⁴ Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA, USA.
⁵ Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, Salt Lake City, UT, USA.
⁶ Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
⁷ Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea.
⁸ Department of Pathology, National Cancer Center, Goyang, Korea.
⁹ College of Basic Medical Sciences, Zhejiang Chinese Medical University (ZCMU), Hangzhou, China.
¹⁰ Department of Obstetrics & Gynaecology, The Chinese University of Hong Kong, Hong Kong, China.
¹¹ Department of Obstetrics and Gynecology, 1st affiliated hospital, Zhejiang Chinese Medical University, Hangzhou, China.
¹² Group of Molecular Epidemiology & Cancer Precision Prevention (GMECPP), Zhejiang Academy of Medical Sciences (ZJAMS), Hangzhou, China.
¹³ Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University School of Medicine, Seoul, Korea.
¹⁴ Department of Obstetrics and Gynecology, Tokai University School of Medicine, Kanagawa, Japan. mmikami@is.icc.u-tokai.ac.jp.

PMID: 30740962
PMCID: PMC6393641
DOI: 10.3802/jgo.2019.30.e40

No abstract available

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest relevant to this article was reported.

References

1. Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri. Int J Gynaecol Obstet. 2018;143(Suppl 2):22–36. - PubMed
1. Matsuo K, Machida H, Mandelbaum RS, Konishi I, Mikami M. Validation of the 2018 FIGO cervical cancer staging system. Gynecol Oncol. 2018 - PMC - PubMed
1. National Comprehensive Cancer Network. Cervical cancer [Internet] Plymouth Meeting, PA: National Comprehensive Cancer Network; c2018. [cited 2018 Nov 6]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/cervical.pdf.
1. Melamed A, Margul DJ, Chen L, Keating NL, Del Carmen MG, Yang J, et al. Survival after minimally invasive radical hysterectomy for early-stage cervical cancer. N Engl J Med. 2018;379:1905–1914. - PMC - PubMed
1. Ramirez PT, Frumovitz M, Pareja R, Lopez A, Vieira M, Ribeiro R, et al. Minimally invasive versus abdominal radical hysterectomy for cervical cancer. N Engl J Med. 2018;379:1895–1904. - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Multidisciplinary perspectives on newly revised 2018 FIGO staging of cancer of the cervix uteri

Affiliations

Multidisciplinary perspectives on newly revised 2018 FIGO staging of cancer of the cervix uteri

Authors

Affiliations

Conflict of interest statement

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical